Gang Liu at ARDD2026: RushData: High-Throughput Experimental Data for AI-Driven Antibody Discovery

What this video covers

A video from ARDD, posted on Oct 23, 2026. It is about the science of aging.

It comes from a research institute, foundation or scientific meeting on aging. We link to it; we don't make or endorse it. Research stages on this site come from published studies, not from videos.

The science of aging: the research →

From the video's description

Gang Liu, BioIntron, presents at the 13th Aging Research and Drug Discovery Meeting: RushData: High-Throughput Experimental Data for AI-Driven Antibody Discovery Key takeaways: – AI has made antibody hits abundant; wet-lab validation is now the bottleneck. – Tests ~3,000 sequences per batch in CHO-K1 cells; supernatant data in 7 days, purified-sample affinity and developability data in 14 days. – Built on a facility producing more than 150,000 antibodies per year; outputs structured for retraining AI models. The Aging Research and Drug Discovery (ARDD) meeting is the world's leading conference dedicated to longevity biotechnology. It convenes top researchers, pharmaceutical executives, regulators, entrepreneurs, and investors to accelerate the translation of aging science into next-generation medicines. ARDD was founded by Alex Zhavoronkov in 2014. Following years of growth in Europe,…

Written by ARDD on YouTube.

More videos like this

Research instituteARDD · Oct 29, 2026Kejun (Albert) Ying at ARDD2026: An open world model for human health and mortalityThe science of agingResearch instituteARDD · Oct 29, 2026Hao Pei at ARDD2026: Aging Is Multidimensional — So Must Be the DataThe science of agingResearch instituteARDD · Oct 29, 2026Yuancheng (Ryan) Lu at ARDD2026: Functional Genomics and Virtual ScreeningThe science of agingResearch instituteARDD · Oct 28, 2026Capital Markets and Philanthropy Panel at ARDD2026: What does AI in Longevity Biotech really need?The science of aging